BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MAGEA11 | Melanoma antigen family A, 11 | | | | | | Group enriched |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
UNC45B | Unc-45 homolog B (C. elegans) | | | | | | Group enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
SYNPO2L | Synaptopodin 2-like | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MYOM2 | Myomesin 2 | | | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
DLEC1 | Deleted in lung and esophageal cancer 1 | Disease related genes Plasma proteins
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
ZIC2 | Zic family member 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
ARMC4 | Armadillo repeat containing 4 | Disease related genes
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
PDE4DIP | Phosphodiesterase 4D interacting protein | Cancer-related genes Disease related genes
| | | | | Group enriched |
TRIM29 | Tripartite motif containing 29 | | | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ATF5 | Activating transcription factor 5 | Transcription factors
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
PSAPL1 | Prosaposin-like 1 (gene/pseudogene) | Predicted secreted proteins
| | | | | Group enriched |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
PKP1 | Plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | Disease related genes Plasma proteins
| | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
LRGUK | Leucine-rich repeats and guanylate kinase domain containing | | | | | | Group enriched |